Perceived Barriers and Support Strategies for Reducing Sodium Intake in Patients with Chronic Kidney Disease: a Qualitative Study

International Journal of Behavioral Medicine

Volumn 22, Issue 4, 2015, Pages 530-539

  Meuleman, Yvette ^a   ten Brinke, Lucia ^a   Kwakernaak, Arjan J ^b   Vogt, Liffert ^c   Rotmans, Joris I ^a   Bos, Willem Jan W ^d   van der Boog, Paul J M ^a   Navis, Gerjan ^b   van Montfrans, Gert A ^c   Hoekstra, Tiny ^a   Dekker, Friedo W ^a   van Dijk, Sandra ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Chronic kidney disease; Lifestyle adherence; Patient centered care; Qualitative research; Reducing sodium intake; Self management interventions

Indexed keywords

SODIUM;

ADULT; AGED; DECISION MAKING; FEMALE; HEALTH CARE PERSONNEL; HUMAN; HUMAN RELATION; INFORMATION PROCESSING; MALE; MIDDLE AGED; MOTIVATION; PERCEPTION; RENAL INSUFFICIENCY, CHRONIC; SOCIAL SUPPORT; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; DECISION MAKING; FEMALE; FOCUS GROUPS; HEALTH PERSONNEL; HUMANS; MALE; MIDDLE AGED; MOTIVATION; PERCEPTION; PROFESSIONAL-PATIENT RELATIONS; RENAL INSUFFICIENCY, CHRONIC; SOCIAL SUPPORT; SODIUM;

EID: 84939256610     PISSN: 10705503     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12529-014-9447-x     Document Type: Article

References (54)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. J Am Med Assoc. 2007;298(17):2038–47.
2. Bosma RJ, Krikken JA, van der Heide JJ H, de Jong PE, Navis GJ. Obesity and renal hemodynamics. Contrib Nephrol. 2006;151:184–202.
3. Baumeister SE, Böger CA, Krämer BK, Döring A, Eheberg D, Fischer B, et al. Effect of chronic kidney disease and comorbid conditions on health care costs: a 10-year observational study in a general population. Am J Nephrol. 2010;31(3):222–9.
4. De Zeeuw D, Hillege HL, de Jong PE. The kidney, a cardiovascular risk marker, and a new target for therapy. Kidney Int Suppl. 2005;98:S25–9.
5. Lambers Heerspink HJ, Holtkamp FA, Parving HH, Navis GJ, Lewis JB, Ritz E, et al. Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int. 2012;82(3):330–7.
6. De Nicola L, Minutolo R, Chiodini P, Zoccali C, Castellino P, Donadio C, et al. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int. 2006;69(3):538–45.
7. Suzuki H, Takenaka T, Kanno Y, Ohno Y, Saruta T. Sodium and kidney disease. Contrib Nephrol. 2007;155:90–101.
8. Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol. 2008;19(5):999–1007.
9. Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Oldroyd S, Benigni A, et al. Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis. 1995;26(6):934–41.
10. Cianciaruso B, Bellizzi V, Minutolo R, Tavera A, Capuano A, Conte G, et al. Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab. 1998;24(4):296–301.
11. Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P. Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol. 2012;23(1):165–73.
12. Martin LR, Williams SL, Haskard KB, Dimatteo MR. The challenge of patient adherence. Ther Clin Risk Manag. 2005;1(3):189–99.
13. Brown IJ, Tzoulaki I, Candeias V, Elliott P. Salt intakes around the world: implications for public health. Int J Epidemiol. 2009;38(3):791–813.
14. Krikken JA, Laverman GD, Navis G. Benefits of dietary sodium restriction in the management of chronic kidney disease. Curr Opin Nephrol Hypertens. 2009;18(6):531–8.
15. Van Zuilen AD, Wetzels JF, Bots ML, Van Blankestijn PJ. MASTERPLAN: study of the role of nurse practitioners in a multifactorial intervention to reduce cardiovascular risk in chronic kidney disease patients. J Nephrol Nurs. 2008;21(3):261–7.
16. Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Inter Suppl. 2013;3 (1):1–150.
17. Kaptein AA, van Dijk S, Broadbent E, Falzon L, Thong M, Dekker FW. Behavioural research in patients with end-stage renal disease: a review and research agenda. Patient Educ Couns. 2010;81(1):23–9.
18. Welch JL, Bennett SJ, Delp RL, Agarwal R. Benefits of and barriers to dietary sodium adherence. West J Nurs Res. 2006;28(2):162–80. discussion 181–9.
19. De Brito-Ashurst I, Perry L, Sanders TAB, Thomas JE, Yaqoob MM, Dobbie H. Barriers and facilitators of dietary sodium restriction amongst Bangladeshi chronic kidney disease patients. J Hum Nutr Diet. 2011;24(1):86–95.
20. Leventhal H, Meyer D, Nerenz D. The common sense representation of illness danger. In: Rachman S, editor. Contributions to medical psychology. New York: Pergamon Press; 1980. p. 7–30.
21. Leventhal H, Brissette IL. The common-sense model of self-regulation of health and illness. In: Cameron LD, Leventhal HE, editors. The self-regulation of health and illness behaviour. London: Routledge; 2003. p. 42–65.
22. Maes S, Karoly P. Self-regulation assessment and intervention in physical health and illness: a review. Appl Psychol. 2005;54(2):267–99.
23. Morse JM. The significance of saturation. Qual Health Res. 1995;5(2):147–9.
24. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.
25. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2:CD000011.
26. Curtin RB, Mapes D, Schatell D, Burrows-Hudson S. Self-management in patients with end stage renal disease: exploring domains and dimensions. Nephrol Nurs J. 2005;32(4):389–95.
27. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. J Am Med Assoc. 2002;288(19):2469–75.
28. Chen SH, Tsai YF, Sun CY, Wu IW, Lee CC, Wu MS. The impact of self-management support on the progression of chronic kidney disease: a prospective randomized controlled trial. Nephrol Dial Transplant. 2011;26(11):3560–6.
29. Wright Nunes JA, Wallston KA, Eden SK, Shintani AK, Ikizler TA, Cavanaugh KL. Associations among perceived and objective disease knowledge and satisfaction with physician communication in patients with chronic kidney disease. Kidney Int. 2011;80(12):1344–51.
30. Safeer RS, Keenan J. Health literacy: the gap between physicians and patients. Am Fam Physician. 2005;72(3):463–8.
31. Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47(8):826–34.
32. Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631–7.
33. Chilcot J, Wellsted D, Farrington K. Illness representations are associated with fluid nonadherence among hemodialysis patients. J Psychosom Res. 2010;68(2):203–12.
34. O’Connor SM, Jardine AG, Millar K. The prediction of self-care behaviors in end-stage renal disease patients using Leventhal’s self-regulatory model. J Psychosom Res. 2008;65(2):191–200.
35. Clark S, Farrington K, Chilcot J. Nonadherence in dialysis patients: prevalence, measurement, outcome, and psychological determinants. Semin Dial. 2014;27(1):42–9.
36. Van Dijk S, Scharloo M, Kaptein AA, Thong MSY, Boeschoten EW, Grootendorst DC, et al. Patients’ representations of their end-stage renal disease: relation with mortality. Nephrol Dial Transplant. 2009;24(10):3183–5.
37. Parfeni M, Nistor I, Covic A. A systematic review regarding the association of illness perception and survival among end-stage renal disease patients. Nephrol Dial Transplant. 2013;28(10):2407–14.
38. Rifkin DE, Laws MB, Rao M, Balakrishnan VS, Sarnak MJ, Wilson IB. Medication adherence behavior and priorities among older adults with CKD: a semistructured interview study. Am J Kidney Dis. 2010;56(3):439–46.
39. Elliott WJ. Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy. J Clin Hypertens. 2009;11(7):376–82.
40. Rollnick S, Miller WR, Butler CC. Motivational interviewing in health care. Helping patients change behavior. New York: Guilford press; 2008.
41. Hettema J, Steele J, Miller WR. Motivational interviewing. Annu Rev Clin Psychol. 2005;1:91–111.
42. VanBuskirk KA, Wetherell JL. Motivational interviewing with primary care populations: a systematic review and meta-analysis. J Behav Med. 2014;37(4):768–80.
43. Murray MA, Brunier G, Chung JO, Craig LA, Mills C, Thomas A, et al. A systematic review of factors influencing decision-making in adults living with chronic kidney disease. Patient Educ Couns. 2009;76(2):149–58.
44. Webster JL, Dunford EK, Hawkes C, Neal BC. Salt reduction initiatives around the world. J Hypertens. 2011;29(6):1043–50.
45. Kim MK, Lopetcharat K, Gerard PD, Drake MA. Consumer awareness of salt and sodium reduction and sodium labeling. J Food Sci. 2012;77(9):S307–13.
46. Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52(1):1–9.
47. Jaana M, Paré G. Home telemonitoring of patients with diabetes: a systematic assessment of observed effects. J Eval Clin Pract. 2007;13(2):242–53.
48. Imai Y, Hosaka M, Elnagar N, Satoh M. Clinical significance of home blood pressure measurements for the prevention and management of high blood pressure. Clin Exp Pharmacol Physiol. 2014;41(1):37–45.
49. Newson RS, Elmadfa I, Biro G, Cheng Y, Prakash V, Rust P, et al. Barriers for progress in salt reduction in the general population. An international study. Appetite. 2013;71:22–31.
50. DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23(2):207–18.
51. Gallant MP. The influence of social support on chronic illness self-management: a review and directions for research. Heal Educ Behav. 2003;30(2):170–95.
52. Lindner H, Menzies D, Kelly J, Taylor S, Shearer M. Coaching for behaviour change in chronic disease: a review of the literature and the implications for coaching as a self-management intervention. Aust J Prim Health. 2003;9(3):177–85.
53. Mattes RD, Donnelly D. Relative contributions of dietary sodium sources. J Am Coll Nutr. 1991;10:383–93.
54. Dötsch M, Busch J, Batenburg M, Liem G, Tareilus E, Mueller R, et al. Strategies to reduce sodium consumption: a food industry perspective. Crit Rev Food Sci Nutr. 2009;49(10):841–51.